Announce Date | 04/23/2025 |
EPS Normalized Actual | $2.28 (Beat by $0.25) |
EPS GAAP Actual | $2.28 (Beat by $0.25) |
Revenue Actual | $2.61B |
Revenue Surprise | Beat by $2610M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.07735 |
EPS GAAP Estimate | $2.07735 |
Revenue Estimate | $2.782368967B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 12.53 | 17.11 | 12.23752 | 12.7754 | 1 |
Dec 2028 | 11.99 | 17.88 | 11.72114 | 12.28834 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.88 | 1.88 | 2.61B | 4.33% | 2610M |
FQ4 2024 (Dec 2024) | 2.07 | 2.07 | 2.583B | 2.21% | 2583M |
FQ3 2024 (Sep 2024) | 2.71 | 2.71 | 2.663B | 4.24% | 2663M |
FQ2 2024 (Jun 2024) | 2.73 | 2.73 | 2.644B | 8.96% | 2644M |
FQ1 2024 (Mar 2024) | 2.54 | 2.54 | 2.497B | 12.13% | 2497M |
FQ4 2023 (Dec 2023) | 4.24 | 4.24 | 2.526B | 8.71% | 2526M |
FQ3 2023 (Sep 2023) | 1.34 | 1.34 | 2.55B | 18.39% | 2550M |
FQ2 2023 (Jun 2023) | 1.06 | 1.06 | 2.407B | 14.91% | 2407M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.07735
Consensus Revenue Estimates
2.782368967B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.54 | -- | 2.49276 | 2.6035 | 1 |
FQ3 2027 (Sep 2027) | 2.86 | -- | 2.80681 | 2.9315 | 1 |
FQ2 2027 (Jun 2027) | 2.79 | -- | 2.73811 | 2.85975 | 1 |
FQ1 2027 (Mar 2027) | 1.9819 | -- | 1.94933 | 2.01587 | 2 |
FQ4 2026 (Oct 2026) | 2.2662 | -- | 2.21783 | 2.31158 | 3 |
FQ3 2026 (Jul 2026) | 2.3502 | -- | 2.30003 | 2.39726 | 3 |
FQ2 2026 (Jun 2026) | 2.0524 | -- | 2.0042 | 2.10311 | 3 |
FQ1 2026 (Mar 2026) | 1.9186 | 2.01 | 1.87355 | 1.96601 | 3 |
FQ4 2025 (Oct 2025) | 2.01092 | -2.94 | 1.968 | 2.05119 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.21B | -- | 3.16B | 3.27B | 2 |
FQ3 2027 (Sep 2027) | 3.22B | -- | 3.17B | 3.28B | 2 |
FQ2 2027 (Jun 2027) | 3.16B | -- | 3.12B | 3.22B | 2 |
FQ1 2027 (Mar 2027) | 2.66B | -- | 2.62B | 2.69B | 2 |
FQ4 2026 (Oct 2026) | 2.96B | -- | 2.91B | 3B | 2 |
FQ3 2026 (Jul 2026) | 3.02B | -- | 2.97B | 3.07B | 2 |
FQ2 2026 (Jun 2026) | 2.8B | -- | 2.75B | 2.85B | 2 |
FQ1 2026 (Mar 2026) | 2.62B | 0.41 | 2.57B | 2.67B | 2 |
FQ4 2025 (Oct 2025) | 2.75B | 6.24 | 2.71B | 2.8B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.88 | 1.88 | 100% | |
FQ4 2024 (Dec 2024) | 2.07 | 2.07 | 100% | |
FQ3 2024 (Sep 2024) | 2.71 | 2.71 | 100% | |
FQ2 2024 (Jun 2024) | 2.73 | 2.73 | 100% | |
FQ1 2024 (Mar 2024) | 2.54 | 2.54 | 100% | |
FQ4 2023 (Dec 2023) | 4.24 | 4.24 | 100% | |
FQ3 2023 (Sep 2023) | 1.34 | 1.34 | 100% | |
FQ2 2023 (Jun 2023) | 1.06 | 1.06 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.61B | $2610M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.58B | $2583M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.66B | $2663M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.64B | $2644M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.5B | $2497M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.53B | $2526M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.55B | $2550M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.41B | $2407M | 100% |